If you are not happy with the results below please do another search
The UK-based Covid-19 Volunteer Testing Network launched April 9 to provide essential additional testing capacity to front-line workers. The project, started by Mike Fischer CBE, helps small laboratories convert to run critical antigen testing and identify Covid-19 cases among local healthcare workers – at no cost to Government. The UK has thousands of small laboratories […]
A recently published study examines the evolutionary and epidemiologic history of an epidemic strain of extensively drug-resistant tuberculosis (XDR-TB) – called LAM4/KZN – in KwaZulu-Natal, South Africa. This strain was first reported in a 2005 outbreak in Tugela Ferry, KwaZulu-Natal, where it was associated with 90 % mortality among predominantly HIV infected individuals, and has […]
Randox Laboratories recently announced its achievement in being awarded the Manufacturer Certification by the National Glycohemoglobin Standardization Program (NGSP) for direct HbA1c testing on three of its clinical chemistry analysers: the RX modena, RX imola and RX daytona+. NGSP is recommended for laboratories conducting diabetes-related clinical trials and is only granted on the basis of […]
Byondis B.V. (formerly Synthon Biopharmaceuticals) announced that Quantum Leap Healthcare Collaborative (Quantum Leap) selected the company’s investigational antibody-drug conjugate (ADC) SYD985 ([vic-]trastuzumab duocarmazine) for a new investigational treatment arm in its ongoing I-SPY 2 TRIAL for neoadjuvant treatment of locally advanced breast cancer. This treatment arm will focus on treatment for HER2-low early-stage breast cancer. […]
Roche will develop its Elecsys Anti-SARS-CoV-2 serology test to detect antibodies in people who have been exposed to SARS-CoV-2 and launch it in early May in countries accepting the CE mark. The company says it is actively working with the FDA for an Emergency Use Authorisation. The Elecsys Anti-SARS-CoV-2 immunoassay is an in vitro test, […]
The battle against cancer hinges on the early detection and then delivery of effective treatment. Oncimmune is working to revolutionise both the detection of cancer and its treatment by harnessing the sophisticated disease-detecting capabilities of the immune system to find cancer in its early stages. Oncimmune’s range of diagnostic tests assist clinicians to identify the […]
BBI Group, the world’s leading independent provider of immuno-diagnostic reagents and contract services, has acquired DIARECT, a leading supplier of autoimmune antigen products. The acquisition enhances BBI’s portfolio and position as a ‘complete’ immunoassay reagent supplier and boosts BBI’s position as the world’s largest diagnostics components company with a market leading antigen portfolio. The UK-based […]
Owlstone Medical and Thermo Fisher Scientific recently announced a collaborative partnership to advance the early diagnosis of cancer and other diseases. This will involve the integration of Orbitrap gas chromatography mass spectrometry (GC-MS) instrumentation into Owlstone Medical’s Breath Biopsy platform, aiding metabolomics studies of breath samples for unique biomarkers that could translate into non-invasive, routine […]
Liquid biopsy is likely to play an increasing role in identifying patients with colorectal cancer (CRC) who are likely to relapse after surgery, and has potential for optimising treatment for individual patients, according to new research. Of 805 patients in the phase III IDEA-FRANCE trial who had liquid biopsy prior to adjuvant chemotherapy for stage […]
by Prof. Michael Vogeser, Dr Judy Stone and Prof. Alan Rockwood While analytical standardization and metrological traceability are well-defined terms, ‘methodological standardization’ in clinical mass spectrometry is still in a developing stage. We propose a framework that facilitates the widespread implementation of this highly complex and very powerful technology and is based on two pillars […]
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
